NEW YORK, Feb. 9, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Columbia Laboratories Inc. (" Columbia" or the "Company") (Nasdaq: CBRX).
The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) the Company's PROCHIEVE product was not delivering desired results; (2) the Food & Drug Administration ("FDA") was unlikely to give approval to Columbia's PROCHIEVE product; and (3) contrary to Company representations, Columbia's future was not "very good" due to the efficacy issues with PROCHIEVE.Columbia's much touted product "PROCHIEVE" is a gel intended to prevent preterm births. On December 14, 2011, the Company issued a press release highlighting the purported results of clinical trials that showed that PROCHIEVE "significantly reduces the risk of preterm birth and neonatal morbidity." Following this announcement, Columbia's stock increased in price significantly. On January 17, 2012, however, the FDA released documents, including trial data, which evidenced PROCHIEVE's ineffectiveness. As a result, Columbia's stock price plunged by over 50%, to $1.10. Then, on January 20, 2012, the FDA Advisory Committee voted 13 to 4 against recommending PROCHIEVE, as the potential risks of the progesterone gel outweighed the benefits. As a result, Columbia's shares declined by an additional $0.874 per share to close at $0.706 per share on January 23, 2012. Request more information now by clicking here: www.faruqilaw.com/CBRX Take Action If you purchased Columbia securities between December 6, 2010 and January 20, 2012 and would like to discuss your legal rights, visit www.faruqilaw.com/CBRX. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding Columbia's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential matter. FARUQI & FARUQI, LLP369 Lexington Avenue, 10th Floor New York, NY 10017Attn: Richard Gonnello, Esq. email@example.com Francis McConville, Esq. firstname.lastname@example.orgTelephone: (877) 247-4292 or (212) 983-9330 SOURCE Faruqi & Faruqi, LLP
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts